Elanco Vietnam Company Limited (Vietnam)

Being wholly-invested by Elanco International Inc., the subject - Elanco Co., Ltd. was established in 2020 after Bayer has completed the sale of its Veterinary-Aquaculture business to US-based Elanco Animal Health. Elanco Animal Health Incorporated – ultimate parent company's shares are listed on New York Stock Exchange under stock code “ELAN”.Elanco Co., Ltd. engages in manufacturing and trading of veterinary drugs, feed supplements for the livestock and aquaculture industries, and aquaculture environment enhancers with products such as Prolan™ Phylavive™, Osamet Shrimp, PROBAI, Virkon A, etc. distributed in the market. In addition, the subject also provides a set of technical solutions for treating water, stabilizing the farming environment, preventing parasites and stimulating shrimp growth. The subject's Elanco Pro-Lab provides disease diagnosis services for shrimp. Along with the domestic market, the products produced by this company are also exported to other Elanco Group's member companies abroad as well as other foreign customers for consumption. The subject recently launched the Elanco Demo Farm program with XpertSea technology to help tally the number of farmed shrimp and accurately predict the health of the shrimp population, helping to attract shrimp farmer customers. And Elanco Probiotics Hatchery - one of Elanco's processes established for aquatic seed production.